Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Adicet Bio

Adicet Bio
2014 FOUNDED
PRIVATE STATUS
61-70 EMPLOYEES
Series B LATEST DEAL TYPE
$80M LATEST DEAL AMOUNT
14 INVESTORS
Description

Developer of allogeneic immunotherapies designed to treat cancer and other diseases. The company is developing novel universal immune cell therapies based on gamma delta T cells engineered with Chimeric Antigen Receptors (CARs) or T Cell Receptors (TCRs), enabling physicians to identify and validate novel disease-specific peptide targets to enhance a patients health and the healthcare system.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Primary Office
  • 200 Constitution Drive
  • Menlo Park, CA 94025
  • United States

+1 (650) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Adicet Bio’s full profile, request a free trial.

Adicet Bio Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC (Series B) 19-Sep-2019 $80M 00000 00000 Completed Pre-Clinical Trials
2. Early Stage VC (Series A) 27-Jan-2016 0000 0000 0000 Completed Startup
1. Accelerator/Incubator 01-Sep-2015 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Adicet Bio Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series B 00,000,000 00.000000 00.00 00.0 00.0 00 00.0 00.000
Series A 00,000,000 00.000000 00.0 00.0 00.0 00 00.0 00.000
Series A-2 2,428,688 $0.000100 $1.2 $1.2 1x $1.2 1.79%
Series A-1 629,633 $0.000100 $0.1 $1.2 $1.2 1x $1.2 0.47%
To view this company’s complete Cap Table, request access »

Adicet Bio Competitors (27)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Rigontec Formerly VC-backed Munich, Germany 000.00 000000&0 000.00
00000 000000000000 Formerly VC-backed New York, NY 00 000.00 000000000000 000.00
000000 00000000000 Corporation Cambridge, MA 000 00000 000000 - 000 00000
0000000000 0000000 Venture Capital-Backed Mont-Saint-Guibert, Belgium 00 00000 00000000000 00000
0000 000000 Formerly VC-backed Santa Monica, CA 000 00000 000000&0 00000
To view this company’s complete list of competitors, request access »

Adicet Bio Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
0000000 000000 000 27-Jan-2016 000000000000000000 Drug Discovery 000 0000000000 00.0
To view this company’s complete investment and acquisition history, request access »

Adicet Bio Subsidiaries (1)

Company Name Industry Location Founded
0000000 000000 000 Drug Discovery Haifa, Israel 0000
To view this company’s complete subsidiary history, request access »

Adicet Bio Investors (14)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
aMoon Fund Venture Capital Minority 000 0000 000000 0
Consensus Business Group Asset Manager Minority 000 0000 000000 0
DSC Investment Venture Capital Minority 000 0000 000000 0
Handok Corporation Minority 000 0000 000000 0
Johnson & Johnson Innovation - JJDC Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 14 investors. Get the full list »

Adicet Bio Executive Team (10)

Name Title Board
Seat
Contact
Info
Anil Singhal Ph.D Chief Executive Officer, President & Board Member
Brian Hogan Chief Financial Officer
Stewart Abbot Ph.D Chief Scientific Officer & Chief Operating Officer
Carrie Krehlik Chief Human Resources Officer
Aya Jakobovits Ph.D Founder, Board Member & Senior Advisor

3 Former Executives

You’re viewing 5 of 10 executives. Get the full list »

Adicet Bio Board Members (9)

Name Representing Role Since Contact
Info
Asish Xavier Ph.D Johnson & Johnson Innovation - JJDC Board Member 000 0000
Aya Jakobovits Ph.D Adicet Bio Founder, Board Member & Senior Advisor 000 0000
Carl Gordon Adicet Bio Board Member 000 0000
Donald Santel Adicet Bio Chairman 000 0000
Erez Chimovits OrbiMed Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »